Mexichem Appoints a New General Counsel

Mexichem Appoints a New General Counsel

Investor News
May 17, 2019


Tlalnepantla de Baz, State of Mexico, May 17, 2019 – Mexichem, S.A.B. of C.V. (BMV: MEXCHEM*) (the “Company” or “Mexichem”) announced today the appointment of Sheldon Hirt as Corporate Vice President and General Counsel.

Mr. Hirt has an extensive experience in international business. Prior to joining Mexichem, Mr. Hirt was General Counsel at Amneal Pharmaceuticals, a specialty pharmaceutical firm, before that he was General Counsel at Progenics Pharmaceuticals, an oncology-focused biotech. He also worked in senior legal roles at Allergan, Barr Pharmaceuticals and Johnson & Johnson.

Mr. Hirt holds a Master’s Degree in International Affairs and a Juris Doctor Degree, both from Columbia University.

Stay updated


Investor BriefsMexichem Solutions


2018 - Mexichem S.A.B. de C.V. ©